Compared with the methods used to identify entire pathways, our method can identify the subpathways more precisely because the results are sometimes highly significant in our subpathway identification, but not significant in the entire pathway identification.
← all excerpts
Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinoma.
1
—
—